BioMimetic Therapeutics’ synthetic, off-the-shelf bone growth factor product, Augment, is not as effective as autograft therapy, top-line, 24-week phase III study results suggest. Both methods are used in joint fusion surgery for patients with chronic pain of the foot and ankle, which can ...
Please Login to read the full article.
